Literature DB >> 15793879

Hepatic steatosis is associated with an increased risk of carotid atherosclerosis.

Henry Volzke1, Daniel-M Robinson, Volker Kleine, Roland Deutscher, Wolfgang Hoffmann, Jan Ludemann, Ulf Schminke, Christof Kessler, Ulrich John.   

Abstract

AIM: Although an association between hepatic steatosis and vascular risk factors has been described, direct relationships between fatty liver and atherosclerosis have not yet been investigated. The aim of the present study has been to investigate those relationships.
METHODS: The Study of Health in Pomerania examined a random population sample aged between 20 and 79 years. A study population of 4 222 subjects without hepatitis B and C infections and without liver cirrhosis was available for the present analysis. Hepatic steatosis was defined sonographically and intima-media thickness (IMT) as well as plaque prevalence were estimated by carotid ultrasound.
RESULTS: The prevalence rate of hepatic steatosis was 29.9%. Among subjects aged > or =45 years, an association between hepatic steatosis and IMT of the carotid arteries was found in bivariate analysis, but not after adjustment for atherosclerotic risk factors. Individuals with fatty liver had more often carotid plaques than persons without fatty liver (plaque prevalence rate 76.8% vs 66.6%; P<0.001). This association persisted after adjustment for confounding factors and was predominantly present in subjects with no to mild alcohol consumption.
CONCLUSION: There is an independent association between hepatic steatosis and carotid atherosclerotic plaques. Metabolic changes due to nonalcoholic fatty liver disease may explain this relationship.

Entities:  

Mesh:

Year:  2005        PMID: 15793879      PMCID: PMC4305889          DOI: 10.3748/wjg.v11.i12.1848

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  34 in total

1.  Association between behavior-dependent cardiovascular risk factors and asymptomatic carotid atherosclerosis in a general population.

Authors:  Jan Luedemann; Ulf Schminke; Klaus Berger; Marion Piek; Stefan N Willich; Angela Döring; Ulrich John; Christof Kessler
Journal:  Stroke       Date:  2002-12       Impact factor: 7.914

2.  Carotid wall thickness is predictive of incident clinical stroke: the Atherosclerosis Risk in Communities (ARIC) study.

Authors:  L E Chambless; A R Folsom; L X Clegg; A R Sharrett; E Shahar; F J Nieto; W D Rosamond; G Evans
Journal:  Am J Epidemiol       Date:  2000-03-01       Impact factor: 4.897

3.  The Tromsø Study. Distribution and population determinants of gamma-glutamyltransferase.

Authors:  O Nilssen; O H Førde; T Brenn
Journal:  Am J Epidemiol       Date:  1990-08       Impact factor: 4.897

4.  Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group.

Authors:  D H O'Leary; J F Polak; R A Kronmal; T A Manolio; G L Burke; S K Wolfson
Journal:  N Engl J Med       Date:  1999-01-07       Impact factor: 91.245

5.  Prevalence of and risk factors for hepatic steatosis in Northern Italy.

Authors:  S Bellentani; G Saccoccio; F Masutti; L S Crocè; G Brandi; F Sasso; G Cristanini; C Tiribelli
Journal:  Ann Intern Med       Date:  2000-01-18       Impact factor: 25.391

6.  Association of coronary heart disease incidence with carotid arterial wall thickness and major risk factors: the Atherosclerosis Risk in Communities (ARIC) Study, 1987-1993.

Authors:  L E Chambless; G Heiss; A R Folsom; W Rosamond; M Szklo; A R Sharrett; L X Clegg
Journal:  Am J Epidemiol       Date:  1997-09-15       Impact factor: 4.897

7.  Liver fat, serum triglycerides and visceral adipose tissue in insulin-sensitive and insulin-resistant black men with NIDDM.

Authors:  M A Banerji; M C Buckley; R L Chaiken; D Gordon; H E Lebovitz; J G Kral
Journal:  Int J Obes Relat Metab Disord       Date:  1995-12

8.  Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome.

Authors:  Giulio Marchesini; Elisabetta Bugianesi; Gabriele Forlani; Fernanda Cerrelli; Marco Lenzi; Rita Manini; Stefania Natale; Ester Vanni; Nicola Villanova; Nazario Melchionda; Mario Rizzetto
Journal:  Hepatology       Date:  2003-04       Impact factor: 17.425

9.  Association between hepatic steatosis, insulin resistance and hyperinsulinaemia as related to hypertension in alcohol consumers and obese people.

Authors:  E Ikai; M Ishizaki; Y Suzuki; M Ishida; Y Noborizaka; Y Yamada
Journal:  J Hum Hypertens       Date:  1995-02       Impact factor: 3.012

10.  The natural history of nonalcoholic fatty liver: a follow-up study.

Authors:  M R Teli; O F James; A D Burt; M K Bennett; C P Day
Journal:  Hepatology       Date:  1995-12       Impact factor: 17.425

View more
  80 in total

1.  Prevalence trends in lifestyle-related risk factors.

Authors:  Henry Völzke; Till Ittermann; Carsten Oliver Schmidt; Sebastian E Baumeister; Sabine Schipf; Dietrich Alte; Reiner Biffar; Ulrich John; Wolfgang Hoffmann
Journal:  Dtsch Arztebl Int       Date:  2015-03-13       Impact factor: 5.594

2.  Assessment of the variations in fat content in normal liver using a fast MR imaging method in comparison with results obtained by spectroscopic imaging.

Authors:  Roy Irwan; Mireille A Edens; Paul E Sijens
Journal:  Eur Radiol       Date:  2007-11-13       Impact factor: 5.315

3.  Menopausal status and hepatic steatosis in a general female population.

Authors:  Henry Völzke; Sabine Schwarz; Sebastian E Baumeister; Henri Wallaschofski; Christian Schwahn; Hans Jörgen Grabe; Thomas Kohlmann; Ulrich John; Martina Dören
Journal:  Gut       Date:  2007-04       Impact factor: 23.059

Review 4.  Increased risk of cardiovascular disease and chronic kidney disease in NAFLD.

Authors:  Enzo Bonora; Giovanni Targher
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2012-05-08       Impact factor: 46.802

5.  The intertwisted correlations among non-alcoholic fatty liver disease, atherosclerosis, and metabolic syndrome.

Authors:  Haruhisa Nakao; Masashi Yoneda
Journal:  J Gastroenterol       Date:  2009       Impact factor: 7.527

6.  Associations between nonalcoholic fatty liver disease and subclinical atherosclerosis in middle-aged adults: the Coronary Artery Risk Development in Young Adults Study.

Authors:  Lisa B VanWagner; Hongyan Ning; Cora E Lewis; Christina M Shay; John Wilkins; J Jeffrey Carr; James G Terry; Donald M Lloyd-Jones; David R Jacobs; Mercedes R Carnethon
Journal:  Atherosclerosis       Date:  2014-06-10       Impact factor: 5.162

7.  Correlation between nonalcoholic fatty liver and cardiovascular disease in elderly hemodialysis patients.

Authors:  Radojica V Stolic; Goran Z Trajkovic; Mirjana M Kostic; Sasa R Sovtic; Andrijana M Odalovic; Biljana D Krdzic; Maja V Sipic; Snezana Lazic; Zorica N Sojevic-Timotijevic
Journal:  Int Urol Nephrol       Date:  2016-02-23       Impact factor: 2.370

Review 8.  Chronic HCV infection and inflammation: Clinical impact on hepatic and extra-hepatic manifestations.

Authors:  Rosa Zampino; Aldo Marrone; Luciano Restivo; Barbara Guerrera; Ausilia Sellitto; Luca Rinaldi; Ciro Romano; Luigi E Adinolfi
Journal:  World J Hepatol       Date:  2013-10-27

9.  Hepatic steatosis in overweight/obese females: new screening method for those at risk.

Authors:  Giovanni Tarantino; Genoveffa Pizza; Annamaria Colao; Fabrizio Pasanisi; Paolo Conca; Patrizia Colicchio; Carmine Finelli; Franco Contaldo; Carolina Di Somma; Silvia Savastano
Journal:  World J Gastroenterol       Date:  2009-12-07       Impact factor: 5.742

10.  Mean platelet volume and its relationship with carotid atherosclerosis in subjects with non-alcoholic fatty liver disease.

Authors:  Guldem Kilciler; Halil Genc; Serkan Tapan; Fatih Ors; Muammer Kara; Nuri Karadurmus; C Nuri Ercin; Yildirim Karslioglu; Selim Kilic; Sait Bagci; M Kemal Erbil; Teoman Dogru
Journal:  Ups J Med Sci       Date:  2010-08-23       Impact factor: 2.384

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.